These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6575697)

  • 41. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
    Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
    Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Functional and diagnostic significance of A-, Bbeta 1-42 and Bbeta 15-42 peptide fragments of fibrin(ogen)].
    Makogonenko EM; Lugovskoĭ EV; Kolesnik LA; Kudinov SA
    Ukr Biokhim Zh (1978); 1992; 64(4):78-82. PubMed ID: 1448878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A role of D-dimer and fibrinopeptide A in diagnosis of a hemostasis system disorders].
    Omarov TI; Sultanov GA; Ragimov VS
    Klin Khir; 2012 Jan; (1):39-41. PubMed ID: 22642087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fibrinolysis and disseminated intravascular coagulation].
    Ikematsu S
    Rinsho Byori; 1985 Jun; Spec No 63():27-36. PubMed ID: 2931536
    [No Abstract]   [Full Text] [Related]  

  • 45. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical significance of fibrinogen degradation products.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract]   [Full Text] [Related]  

  • 47. [Interaction of a peptide inhibitor with two forms of monomeric fibrin differing in the degree of activation].
    Chiriat'ev EA; Leonova OP; Byshevskiĭ ASh
    Ukr Biokhim Zh (1978); 1989; 61(1):3-9. PubMed ID: 2741239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibrinogen, fibrinopeptide A and fibrin monomers.
    Semeraro N
    Acta Clin Belg; 1977; 32(6):380-5. PubMed ID: 616748
    [No Abstract]   [Full Text] [Related]  

  • 49. Domains in fibrinogen of importance for the fibrinogen-fibrin formation.
    Hessel B; Kudryk B; Bombäck B
    Bibl Haematol; 1977; 44():117-22. PubMed ID: 617775
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of fibrinogen on fibrin polymerization. Ultracentrifugation studies.
    Preissner KT; Rötker J; Selmayr E; Fasold H; Müller-Berghaus G
    Biochim Biophys Acta; 1985 Jul; 829(3):358-64. PubMed ID: 4005267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.
    Scheraga HA
    Ann N Y Acad Sci; 1983 Jun; 408():330-43. PubMed ID: 6575693
    [No Abstract]   [Full Text] [Related]  

  • 52. Coagulopathy of disseminated neuroblastoma.
    Scott JP; Morgan E
    J Pediatr; 1983 Aug; 103(2):219-22. PubMed ID: 6875712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzymatic and chemical cross-linking of fibrinogen.
    Furlan M; Beck EA
    Bibl Haematol; 1977; 44():123-8. PubMed ID: 104705
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
    Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
    Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [[Methods and clinical significance of paracoagulation phenanthroline test]n].
    Momot AP; Elykkomov VA; Barkagan ZS
    Klin Lab Diagn; 1996; (4):17-20. PubMed ID: 8963550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasma.
    Gaffney PJ; Edgell T; Creighton-Kempsford LJ; Wheeler S; Tarelli E
    Br J Haematol; 1995 May; 90(1):187-94. PubMed ID: 7786784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel aspects of fibrin(ogen) fragments during inflammation.
    Jennewein C; Tran N; Paulus P; Ellinghaus P; Eble JA; Zacharowski K
    Mol Med; 2011; 17(5-6):568-73. PubMed ID: 21210072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of phosphorylation in vitro of human fibrinogen with protein kinase C on thrombin-induced gelation.
    Heldin P; Hessel B; Humble E; Blombäck B; Engström L
    Thromb Res; 1987 Jul; 47(1):93-9. PubMed ID: 3660346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of desarginine fibrinopeptide B in human blood.
    Eckhardt T; Nossel HL; Hurlet-Jensen A; La Gamma KS; Owen J; Auerbach M
    J Clin Invest; 1981 Mar; 67(3):809-16. PubMed ID: 7204556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.